Revvity Inc vs Synchrony Financial — how do they compare? Revvity Inc trades at $110.7 (market cap $11.87B), while Synchrony Financial trades at $71.7 (market cap $24.69B). The key difference: Synchrony Financial is far larger — about 2.1× Revvity Inc's market cap, and Synchrony Financial pays the higher dividend (1.63%). Which is the better fit depends on your goals.
| RVTY | SYF | |
|---|---|---|
Market Cap | $11.87B | $24.69B |
Sector | Technology | Financials |
52-Week High | $117.75 | $88.47 |
52-Week Low | $82.26 | $63.78 |
Enterprise Value | $14.36B | — |
Dividend Yield | 0.26% | 1.63% |
Trailing returns across standard periods
Latest headlines on both assets
Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →Synchrony Financial is a premier consumer financial services company and the largest provider of private-label credit cards in the United States. Spun off from GE Capital in 2014, it operates through a unique B2B2C model, embedding its financing products within the ecosystems of major partners like Amazon, Lowe’s, and PayPal. Synchrony leverages deep data analytics and a diverse multi-platform strategy—spanning retail, health, and auto—to drive customer loyalty and provide specialized credit solutions at the point of sale.
Read more on SYF →